We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
SF
201
Synovus Financial
Georgia
– -$715K -13,293 Closed
RJFSA
202
Raymond James Financial Services Advisors
Florida
– -$708K -13,133 Closed
ARMC
203
American Research & Management Company
Massachusetts
– -$697K -12,931 Closed
RCM
204
Riverhead Capital Management
Delaware
– -$654K -12,120 Closed
IAS
205
IMA Advisory Services
Colorado
– -$647K -12,006 Closed
LPL Financial
206
LPL Financial
California
– -$641K -11,889 Closed
CA
207
Commerzbank Aktiengesellschaft
Germany
– -$626K -11,613 Closed
KBC Group
208
KBC Group
Belgium
– -$617K -11,429 Closed
PTC
209
Philadelphia Trust Company
Pennsylvania
– -$611K -11,331 Closed
FLPIM
210
F.L. Putnam Investment Management
Massachusetts
– -$605K -11,228 Closed
MC
211
Muhlenkamp & Co
Pennsylvania
– -$600K -11,127 Closed
HP
212
Hikari Power
Japan
– -$593K -11,000 Closed
NSEDCP
213
NJ State Employees Deferred Compensation Plan
New Jersey
– -$593K -11,000 Closed
SCA
214
Secor Capital Advisors
New York
– -$585K -10,848 Closed
GC
215
Globeflex Capital
California
– -$583K -10,810 Closed
MCIM
216
Meadow Creek Investment Management
Georgia
– -$575K -10,670 Closed
HI
217
HBK Investments
Texas
– -$567K -10,522 Closed
SAM
218
Symphony Asset Management
California
– -$561K -10,395 Closed
LSV Asset Management
219
LSV Asset Management
Illinois
– -$558K -10,350 Closed
IG
220
ING Group
Netherlands
– -$558K -10,345 Closed
American Century Companies
221
American Century Companies
Missouri
– -$551K -10,220 Closed
BG
222
Bellevue Group
Switzerland
– -$550K -10,200 Closed
XK
223
Xact Kapitalforvaltning
Sweden
– -$547K -10,139 Closed
SAM
224
Shell Asset Management
Netherlands
– -$541K -10,038 Closed
SBA
225
Seven Bridges Advisors
New York
– -$541K -10,033 Closed
7 8
9
10 11

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.